Summary
High-dose methotrexate and Leucovorin (calcium folinate) rescue was evaluated as induction chemotherapy in combination with cyclophosphamide, doxorubicin, and vincristine in 21 patients with extensive-stage small cell lung cancer. Nine (42%) of 21 had a complete remission. The median duration of remission has been short (5 months), and attempts are now under way to improve consolidation chemotherapy. In general, the degree of myelotoxicity was not increased by the high-dose methotrexate, although the antitumor activity of the combination appears enhanced. Attempts at further increasing the intensity of this regimen or comparative trials with other therapy appears warranted.
This research was supported in part by JFCF, ACS 394; PHSG 5M01 RR-95; Division of Cancer Treatment of the National Cancer Institute
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abeloff MD, Ettinger DS, Khouri N (1970) Intensive induction therapy for small cell carcinoma of the lung (SCC). Proc Am Soc Clin Oncol 20:328
Brereton HD, Kent CA, Johnson RE (1977) Chemotherapy and radiotherapy for small cell lung cancer: A remedy for past therapeutic failure. Proc Am Soc Clin Oncol 18:275
Broder LE, Cohen MH, Selawry OS (1977) Treatment of bronchogenic carcinoma II. Small cell lung cancer. Cancer Treat Rev 4:219–260
Bunn PA, Cohen MH, Ihde DC, Fossieck BE, Matthews MJ, Minna JD (1977) Advances in small cell bronchogenic carcinoma. Cancer Treat Rep 61:333–342
Cohen MH, Creaven PJ (1977) Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 61:349–354
Einhorn LH, Bond WH, Hornback N, Tekjoe B (1978) Long-term results in combined modality treatment of small cell carcinoma of the lung. Semin Oncol 5:309–313
Greco FA, Brereton HD, Zimbler H, Merrill JM, Johnson RE (1976) Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med 85:294–298
Greco FA, Einhorn LH, Richardson RL, Oldham RK (1978) Small cell lung cancer: Progress and perspectives. Semin Oncol 5:323–335
Greco FA, Richardson RL, Stroup SL, Shulman S, Oldham RK (1978) Therapy of oat-cell carcinoma of the lung: Complete remissions, acceptable complications and improved survival. Br Med J 2:10–11
Kent CH, Brereton HD, Johnson RE (1977) “Total” therapy for oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 2:427–432
Merrill JM, Brereton HD, Kent CH, Johnson RE (1976) Anorectal disease in patients with non-hematological malignancy. Lancet 1:1105–1107
Pitman E, Frei E (1977) Weekly methotrexate citrovorum (MTX-CF) with alkalinization: Tumor response in pase II study. Proc Am Assoc Cancer Res 18:124
Skarin A, Canellos G, Frei E (1978) Therapy of unfavorable histology non-Hodgkin’s lymphoma with high dose methotrexate and citovorum rescue, bleomycin, adriamycin, cyclophosphamide, Oncovin, and Decadron. Proc Am Soc Clin Oncol 19:400
Skarin A, Greene H, Canellos G, Takovrin R, Frei E (1979) High dose methotrexate with citrovorum factor rescue alternating with combination chemotherapy in small cell lung cancer. Proc Am Soc Clin Oncol 20:238
Stoller RG, Hande KR, Jacobs S, Chabner B (1977) Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. N Engl J Med 297:630–633
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Greco, F.A., Hande, K.R., Richardson, R.L., Oldham, R.K. (1980). High-Dose Methotrexate in Combination Chemotherapy for Small Cell Lung Cancer. In: Mathé, G., Muggia, F.M. (eds) Cancer Chemo- and Immunopharmacology. Recent Results in Cancer Research, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81488-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-81488-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81490-7
Online ISBN: 978-3-642-81488-4
eBook Packages: Springer Book Archive